Whole blood miRNA expression analysis reveals miR-3613-3p as a potential biomarker for dedifferentiated liposarcoma
Authors:
- 29 May 2018
- journal article
- research article
- Published by SAGE Publications in Cancer Biomarkers
- Vol. 22 (2) , 199-207
Abstract
BACKGROUND: Liposarcoma constitute about 13% of all soft tissue sarcoma and are associated with a high risk of metastases. As the preoperative differentiation between benign and malign lipomatous tumors is restricted to magnetic resonance imaging, coKeywords
This publication has 38 references indexed in Scilit:
- Plasma Processing Conditions Substantially Influence Circulating microRNA Biomarker LevelsPLOS ONE, 2013
- Methylated DNA and microRNA in Body Fluids as Biomarkers for Cancer DetectionInternational Journal of Molecular Sciences, 2013
- MiR-155 Is a Liposarcoma Oncogene That Targets Casein Kinase-1α and Enhances β-Catenin SignalingCancer Research, 2012
- Let‐7 MicroRNA and HMGA2 levels of expression are not inversely linked in adipocytic tumors: Analysis of 56 lipomas and liposarcomas with molecular cytogenetic dataGenes, Chromosomes and Cancer, 2011
- Expression of miRNA-130a in Nonsmall Cell Lung CancerThe American Journal of the Medical Sciences, 2010
- Machine learning study of several classifiers trained with texture analysis features to differentiate benign from malignant soft‐tissue tumors in T1‐MRI imagesJournal of Magnetic Resonance Imaging, 2010
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseasesCell Research, 2008
- Monocyte Chemoattractant Protein-1 Induces a Novel Transcription Factor That Causes Cardiac Myocyte Apoptosis and Ventricular DysfunctionCirculation Research, 2006
- Differential sensitivity of liposarcoma subtypes to chemotherapyEuropean Journal of Cancer, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001